アヤワスカ
(ayahuasca から転送)
出典: フリー百科事典『ウィキペディア(Wikipedia)』 (2023/07/06 15:38 UTC 版)
アヤワスカ(ケチュア語: Ayahuasca、Ayawaska)は、アマゾン北西部で伝統的に用いられている幻覚剤[1]。ペルーの国家文化遺産[2][3]。
- ^ a b dos Santos, Rafael G.; Bouso, José Carlos; Hallak, Jaime E. C.; et al. (2017). “Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies”. Therapeutic Advances in Psychopharmacology 7 (4): 141–157. doi:10.1177/2045125316689030. PMC 5433617. PMID 28540034 .
- ^ a b c d e 山本誠「シャーマニズムを依存症治療に接合する- ペルーアマゾンの「歌う家」、薬物依存リハビリセンター「タキワシ」訪問記」『四天王寺大学紀要』第62号、2016年、287-316頁、NAID 110010059957。
- ^ a b c d e f g h i Garcia-Romeu, Albert; Kersgaard, Brennan; Addy, Peter H.; et al. (2016). “Clinical applications of hallucinogens: A review.”. Experimental and Clinical Psychopharmacology 24 (4): 229–268. doi:10.1037/pha0000084. PMC 5001686. PMID 27454674 .
- ^ a b c Palhano-Fontes F, Barreto D, Onias H, et al. (2019-3). “Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial”. Psychol Med 49 (4): 655–663. doi:10.1017/S0033291718001356. PMC 6378413. PMID 29903051 .
- ^ a b c d 石川勇一「アマゾン・ネオ・シャーマニズムの心理過程の現象学的・仏教的研究」『トランスパーソナル心理学/精神医学』第15巻第1号、2016年2月、62-86頁、NAID 40020957856。
- ^ a b c d e f g h i Riba, J. (2003). “Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics”. Journal of Pharmacology and Experimental Therapeutics 306 (1): 73–83. doi:10.1124/jpet.103.049882. PMID 12660312 .
- ^ Anwar, Yasmin (2019年5月6日). “Ayahuasca fixings found in 1,000-year-old Andean sacred bundle” (英語). Berkeley News. 2019年5月16日閲覧。
- ^ Erin Blakemore; 訳・牧野建志 (2019年5月14日). “米国で注目の「伝統的幻覚剤」、最古の証拠発見か”. ナショナルジオグラフィック日本版. 2021年2月4日閲覧。 同様の記事: Kristina Killgrove; 上田裕資 (2019年5月18日). “南米ボリビアで発見された1000年前のコカインや幻覚ドラッグ”. (フォーブス ジャパン. 2021年2月5日閲覧。
- ^ Schultes, Richard Evans, and Albert Hofmann. Plants of the Gods: Their Sacred, Healing and Hallucinogenic Properties. Healing Arts Press, 1992.
- ^ Erowid. Erowid Ayahuasca Vault : Timeline, Erowid.org, 1996.
- ^ Pinchbeck, Daniel. Breaking Open the Head: A Psychedelic Journey into the Heart of Contemporary Shamanism. Broadway, 2002.
- ^ a b c d e f g Malcolm, Benjamin J.; Lee, Kelly C. (2017). “Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?”. Mental Health Clinician 7 (1): 39–45. doi:10.9740/mhc.2017.01.039 .
- ^ a b Morales-García, Jose A.; de la Fuente Revenga, Mario; Alonso-Gil, Sandra; et al. (2017). “The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro”. Scientific Reports 7 (1): 5309. doi:10.1038/s41598-017-05407-9. PMC 5509699. PMID 28706205 .
- ^ Salak, Kira. “Hell and back”, National Geographic Adventure. 8.2, 2006, 54(10).
- ^ McKenna DJ, Callaway JC, Grob CS, et al., "Human Pharmacology of Hoasca, a Plant Hallucinogen Used in Ritual Context in Brazil", Journal of Nervous and Mental Disorder 184, 1996, pp.86-94.
- ^ a b c d e Osório, Flávia de L.; Sanches, Rafael F.; Macedo, Ligia R.; dos Santos, Rafael G.; Maia-de-Oliveira, João P.; Wichert-Ana, Lauro; de Araujo, Draulio B.; Riba, Jordi et al. (2015). “Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report”. Revista Brasileira de Psiquiatria 37 (1): 13–20. doi:10.1590/1516-4446-2014-1496. PMID 25806551 .
- ^ Zeifman RJ, Singhal N, Dos Santos RG, Sanches RF, de Lima Osório F, Hallak JEC, Weissman CR (2021-2). “Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial”. Psychopharmacology (Berl) 238 (2): 453–459. doi:10.1007/s00213-020-05692-9. PMID 33118052.
- ^ Sampedro, Frederic; de la Fuente Revenga, Mario; Valle, Marta; et al. (2017). “Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities”. International Journal of Neuropsychopharmacology 20 (9): 698–711. doi:10.1093/ijnp/pyx036. PMC 5581489. PMID 28525587 .
- ^ Stafford, Peter. Psychedelics Encyclopedia, Third Expanded Edition. Ronin Publishing, Inc., 1992.
- ^ a b dos Santos, Rafael G; Balthazar, Fermanda M; Bouso, José C; et al. (2016). “The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging”. Journal of Psychopharmacology 30 (12): 1230–1247. doi:10.1177/0269881116652578. PMID 27287824.
- ^ Kuypers, K. P. C.; Riba, J.; de la Fuente Revenga, M.; et al. (2016). “Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking”. Psychopharmacology 233 (18): 3395–3403. doi:10.1007/s00213-016-4377-8. PMC 4989012. PMID 27435062 .
- ^ Mazza, Marianna; Bouso, José Carlos; González, Débora; et al. (2012). “Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study”. PLoS ONE 7 (8): e42421. doi:10.1371/journal.pone.0042421. PMC 3414465. PMID 22905130 .
- ^ Nutt, David J.; Rucker, James J.H.; Iliff, Jonathan; et al. (2017). “Psychiatry & the psychedelic drugs. Past, present & future”. Neuropharmacology. doi:10.1016/j.neuropharm.2017.12.040. PMID 29284138 .
- ^ Andritzky, W. “Sociopsychotherapeutic functions of ayahuasca healing in Amazonia”, Journal of Psychoactive Drugs. 21(1), 1989, pp.77-89.
- ^ a b c d e f g h i j k l m ジム・デコーン 著、竹田純子、高城恭子 訳『ドラッグ・シャーマニズム』1996年、193-200頁。ISBN 4-7872-3127-8。Psychedelic Shamanism, 1994.
- ^ Xavier Francuski (2018年2月3日). “How To Prepare For Your First Ayahuasca Experience”. Kahpi. 2018年2月1日閲覧。
- ^ Saklad, Stephen R. Erowid MAOI Vault : Foods to Avoid, Micromedex Inc, 1994.
- ^ a b Halpern, John H (2004). “Hallucinogens and dissociative agents naturally growing in the United States” (pdf). Pharmacology & Therapeutics 102 (2): 131–138. doi:10.1016/j.pharmthera.2004.03.003. PMID 15163594 .
- ^ a b c d Ott, Jonathan (1999). “Pharmahuasca: Human Pharmacology of Oral DMT Plus Harmine”. Journal of Psychoactive Drugs 31 (2): 171–177. doi:10.1080/02791072.1999.10471741. PMID 10438001.
- ^ ジョン・ホーガン 著、竹内薫 訳『科学を捨て、神秘へと向かう理性』徳間書店、2004年、291頁。ISBN 4-19-861950-6。 Rational mysticism, 2003.
- ^ International control of the preparation "ayahuasca", letter from the United Nations International Narcotics Control Board
- ayahuascaのページへのリンク